Every material Form 8-K RF Acquisition Corp III has filed with the SEC since February 23, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
RF Acquisition Corp III, a special purpose acquisition company, signed a Business Combination Agreement with HCC Healthcare Pte. Ltd., a Singapore private company whose operating subsidiaries are in Taiwan. If completed, RF Acquisition Corp III will merge into a subsidiary of HCC Healthcare, and HCC Healthcare expects its shares to be listed on Nasdaq or the NYSE. The deal requires approval by RF Acquisition Corp III shareholders and an effective Form F-4, with closing expected in the fourth quarter of 2026.
HCC Healthcare's pre-transaction equity value is set at $500,000,000 on a fully diluted basis, with each ordinary share valued at $10.00 after its recapitalization.
RF Acquisition Corp III will merge into Merger Sub, which will become a wholly owned subsidiary of HCC Healthcare.
Closing is expected in the fourth quarter of 2026, subject to shareholder approval, effectiveness of the Form F-4, and listing approval.
Either party may terminate if the closing has not occurred within 270 days after the agreement date, among other conditions.
RF Acquisition Corp III, a blank check company, said holders of its 10,000,000 units may separately trade ordinary shares and rights starting February 26, 2026. Units not separated will keep trading as RFAMU, while the separated shares and rights are expected to trade as RFAM and RFAMR. This is a routine administrative step that does not change the company's business or the terms of its securities.
Separate trading of ordinary shares and rights begins February 26, 2026
Each unit consists of one ordinary share and one right, entitling the holder to one-tenth of one ordinary share upon an initial business combination
Separated securities expected to trade on Nasdaq as RFAM (shares) and RFAMR (rights); units remain RFAMU
Holders must have brokers contact Continental Stock Transfer & Trust Company to separate units
RF Acquisition Corp III completed its initial public offering of 10,000,000 units at $10.00 per unit on February 17, 2026, generating gross proceeds of $100,000,000. The company has not commenced operations and will not generate operating revenue until it completes a business combination, so shareholder value depends on that future deal.
IPO of 10,000,000 units at $10.00 per unit on February 17, 2026, for gross proceeds of $100,000,000
Private placement of 350,000 units at $10.00 per unit for $3,500,000 to sponsor Alfa 30 Limited and its designees, and EarlyBirdCapital, Inc.
$100,000,000 placed in the trust account on February 17, 2026
On February 19, 2026, underwriters did not exercise the over-allotment option; sponsor will forfeit 500,000 ordinary shares
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every RF Acquisition Corp III filing is on SEC EDGAR ↗. 8-K briefs of other companies →